Article of the Month

Understanding Messenger RNA and Other SARS-CoV-2 Vaccines

In mid-November, Pfizer/BioNTech were the first with surprising positive protection interim data for their coronavirus vaccine, BNT162b2. A week later, Moderna released interim efficacy results showing its coronavirus vaccine, mRNA-1273, also protected patients from developing SARS-CoV-2 infections. Both studies included mostly healthy adults. A diverse ethnic and racial vaccinated population was included. A reasonable number of persons aged over 65…read more

Health Articles

Health Articles

Fitness Articles

Fitness Articles

Brain Waves Articles

Fashion Articles

Food Articles

Fashion Articles